MAP2K7 and colorectal carcinoma: Moreover, crizotinib can synergistically increase the MEK-inhibitor AZD6244-induced apoptosis and growth inhibition in vitro and in vivo in KRAS-mutated CRC cells (Van Schaeybroeck et al., 2014).